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Live cell imagingAnogenital cancers and head and neck cancers are causally associated with infection by high-risk human
papillomavirus (HPV). The mechanism by which high-risk HPVs contribute to oncogenesis is poorly
understood. HPV16 encodes three genes (HPV16 E5, E6, and E7) that can transform cells when expressed
independently. HPV16 E6 and E7 have well-described roles causing genomic instability and unregulated cell
cycle progression. The role of HPV16 E5 in cell transformation remains to be elucidated. Expression of HPV16
E5 results in enlarged, polyploid nuclei that are dependent on the level and duration of HPV16 E5 expression.
Live cell imaging data indicate that these changes do not arise from cell–cell fusion or failed cytokinesis. The
increase in nuclear size is a continual process that requires DNA synthesis. We conclude that HPV16 E5
produces polyploid cells by endoreplication. These ﬁndings provide insight into how HPV16 E5 can
contribute to cell transformation.University of Oklahoma Health
Biomedical Sciences Building,
271 3548.
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Most anogenital (Bosch et al., 2002) and head and neck (Gillison
et al., 2000) cancers are causally linked with infection with certain
types of HPV; however, the mechanisms by which this occurs are not
fully understood. Understanding how the oncogenes encoded by HPV
induce cellular changes during tumorigenesis is critical for developing
successful interventions.
There are at least 120 different types of HPV; however, only 13 of
these are considered oncogenic (16, 18, 31, 33, 35, 39, 45, 51, 52, 56,
58, 59, and 68). Of these 13 HPV types, HPV16 is the most prevalent. It
is present in 57% of cervical cancers (Clifford et al., 2003) and 90% of
HPV-positive head and neck tumors (Gillison et al., 2008).
Clues as to how HPV transforms normal cells into a cancerous ones
have been shown to be dependent on expression of genes in the early
region of the viral genome. HPV16 is an approximately 8000 bp
circular DNA virus with eight open reading frames (ORFs). Of those,
three are known to encode oncogenes—proteins that can mediate cell
transformation when individually transfected into a cell. Of the three
HPV16 oncogenes, two (E6 and E7) have been well characterized for
their ability to inhibit cell cycle regulators, namely p53 and Rb (Joneset al., 1997; Werness et al., 1990). In addition, both oncogenes have
been shown to associate with a number of other proteins, and
expression of E6 and E7 results in genomic instability, a characteristic
of many cancers (Nakamura et al., 2001). Thus, E6 and E7 have well
established roles in tumor propagation.
The role of the third oncogene, E5, has been less clear. HPV16 E5 is
sufﬁcient to transformmouse ﬁbroblasts and keratinocytes in culture,
as assessed by anchorage independent growth and colony formation
assays (Leechanachai et al., 1992; Pim et al., 1992; Straight et al.,
1993). Co-expression of E5 with either E6 or E7 enhances the
transforming properties of either protein alone (Bouvard et al., 1994;
Stoppler et al., 1996; Valle and Banks, 1995).
This in vitro analysis has been complemented with studies using
transgenic mice. Williams et al. (2005) have demonstrated that
expression of the HPV16 E5 oncogene [driven by the basal epithelium
speciﬁc promoter (K14)] is sufﬁcient to cause epidermal hyperplasia and
the formation of spontaneous skin tumors. When the entire HPV16
genome is expressed, the size of the tumor increases as compared tomice
expressing only E6 and E7 (Riley et al., 2003). These in vivo data provide
additional evidence that HPV16 E5 transforms cells independently as
well as enhances the transforming properties of other HPV16 oncogenes.
The exact molecular mechanisms by which E5 participates in
transformation are unclear. Identifying a molecular role for E5 in
infected tissues has been difﬁcult due to its low level of protein
expression, rare integration of the E5 gene into the host chromosome,
and a lack of reagents, antibodies, and animal models (Conrad et al.,
343L. Hu et al. / Virology 405 (2010) 342–3511994; Disbrow et al., 2005; Oelze et al., 1995; Oetke et al., 2000;
Straight et al., 1995). The diverse functions proposed for E5 include
protecting the cell against apoptosis (Kabsch and Alonso, 2002; Zhang
et al., 2002), interfering with cell–cell communication (Oelze et al.,
1995), and inhibition of antigen presentation in infected cells (Zhang
et al., 2003). The most commonly accepted model is that the E5 gene
product potentiates the signaling of the epidermal growth factor
receptor (EGFR) by slowing EGFR endocytic trafﬁcking and degrada-
tion (Straight et al., 1995, 1993; Zhang et al., 2005).
While these proposed mechanisms are reasonable means of
promoting the unregulated cell growth that is characteristic of cancer
cells, it is difﬁcult to reconcile these proposed functions with the
reported proﬁle of E5 expression. Due to a lack a reliable antibodies to
the native HPV16 E5 protein, the best estimation of expression of
HPV16 E5 comes from monitoring the generation of HPV16 E5 mRNA
(Stoler et al., 1992). The levels of HPV16 E5 mRNA are highest
immediately after infection and trail off as the infected epithelial cells
differentiate. In fact, most HPV16 positive tumors and cell lines
derived from cervical cancers do not have detectable levels of E5
mRNA (Pater and Pater, 1985; Schwartz et al., 1985; Stoler et al.,
1992). Based on the kinetics of HPV16 E5 expression, it has been a
widely held belief that the role of HPV16 E5 is in the initiation of
oncogenesis (zur Hausen, 1996; zur Hausen, 2000).
We have recently developed amodel system that allows detectable
HPV16 E5 to be expressed in large populations of cells. Using this
model, we discovered that expression of HPV16 E5 leads to two
noteworthy changes in cell morphology: binucleated cells (Hu et al.,
2009) and enlarged nuclei. Both of these phenotypes are characteristic
of precancerous lesions. Further, these changes are consistent with
HPV16 E5 playing a role in initiating oncogenesis.
We have previously reported that the binucleated cells arise
through cell–cell fusion (Hu et al., 2009). However, the relationship, ifFig. 1. Expression ofHPV16E5 increases nuclear size. A) tTA-HaCaT cellswere uninfected or infe
units/cell) in the absence (HA-E5) or presence (E5-HA+tet) of tetracycline (1 μg/ml). A) Seven
with the12CA5 (anti-HA)mousemonoclonal antibody andnucleiwere stainedwithDAPI. Image
Size bar is 10 μm. B) Quantiﬁcation of the nuclear size in μm. This graph shows the average±S
experiments. * indicates a p-value of b0.05 (two-tailed, unpaired t-test) as compared to time-ma
a 16% Tris–tricine gel and immunoblotted with the 12CA5 (anti-HA) mouse monoclonal antibany, between ether cell–cell fusion and enlarged nuclei was unclear.
Here we have performed a systematic analysis each cellular change
initiated by HPV16 E5 to determine the relationship between these
phenotypes and how they might contribute to oncogenesis. Based on
our work and the ﬁndings of others, HPV16 E5, like many viral
proteins, has multiple effects on the cell. These myriad roles may be at
the root of why the true pathological role(s) of HPV16 E5 has been so
difﬁcult to elucidate.
In this manuscript, we report that expression of HPV16 E5 in human
keratinocytes is sufﬁcient to produce enlarged nuclei. The change in
nuclear size is accompanied by an increase in cellular DNA content and
chromosomal number. Live cell video microscopy indicates these
cellular changes are not the result of failed cell division or cell–cell
fusion. Rather, the nucleus increases in size gradually and requires DNA
synthesis for its growth. From these data, we conclude that HPV16 E5
causes an increase in nuclear size through endoreplication.
Results
HPV16 E5 is necessary and sufﬁcient for the formation of enlarged nuclei
In order to examine the role of HPV16 E5 expression, we generated
tetracycline-regulatable adenoviruses that encode a codon-optimized
HPV16 E5 that was tagged with an HA epitope on either the amino- or
carboxy-terminus, termed HPV16 HA-E5 or HPV16 E5-HA, respec-
tively. The codon optimization enhances expression of the E5 protein
(Disbrow et al., 2003) and the epitope tags permit detection of the
protein to which there are no reliable antibodies commercially
available. These adenoviruses can only be expressed in cells that
express the tetracycline transactivator (tTA); expression of these
genes is ablated in the presence of tetracycline. For these experiments,
we have stably transfected the tTA into HaCaT cells (tTA-HaCaT cells),ctedwith eitherno adenovirus (No virus), or HPV16HA-E5 adenovirus (20 plaque forming
ty-two hours after infection, cells were ﬁxed and stained by indirect immunoﬂuorescence
swerecollectedusingOlympusAX70 epiﬂuorescentmicroscopewithQ-Capture software.
.E.M. nuclear diameter frommore than 150mono-nucleated cells from three independent
tched cells infected in the presence of tetracycline. C) Cell lysates (30 μg)were resolved on
ody or α-tubulin antibody as a loading control.
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tive (Hu et al., 2009).
When HPV16 HA-E5 is expressed in HaCaT cells, the nuclei become
enlarged and increase in size over time (Fig. 1A). There is no change in
the size of the nucleus of parental HaCaT cells, or cells that have been
infected with the HPV16 HA-E5 adenovirus in the presence of
tetracycline to ablate protein expression. Over the course of 72 h of
HPV16 HA-E5 expression, the average nucleus size increases ∼50%
(Fig. 1B). Similar changes in nuclear size were observed when HPV16
E5-HA was expressed (data not shown). Protein expression was
conﬁrmed by both indirect immunoﬂuorescence (Fig. 1A) and
immunoblot (Fig. 1C).
The increase in nuclear size did not reﬂect a change in only a few
HPV16 HA-E5 expressing cells, but rather a shift in size of the whole
population. When the data from over 500 cells from three indepen-
dent experiments is plotted as a histogram, it is clear that almost the
entire population of HPV16 HA-E5 expressing cells has increased its
nuclear size while maintaining a Gaussian distribution (Supplemental
Fig. 1).
Similar increases in nuclear size can be seen in NIH 3T3 cells
transfected with HPV16 HA-E5 (Supplemental Fig. 2). The smaller
increase in nuclear size is likely a reﬂection of the lower level of
protein expression since adenoviral gene transfer is more efﬁcient and
produces more protein than transient transfection. Fig. 4 demon-
strates that the changes mediated by HPV16 E5 expression are dose
dependent.
In order to assess whether E5 would cause the nucleus to enlarge
in the context of the native virus, we transfected cells with the entire
HPV16 genome. As a control for the potential effects of the other
HPV16 viral proteins, we transfected cells with amutant HPV16with a
frameshift mutation in the E5 protein (HPV16 E5 fs) which prevents a
functional protein from being produced (Genther et al., 2003). InFig. 2. Expression of HPV16 E5 in the context of the entire HPV16 genome causes an increas
pEGFP and the wild type HPV16 genome (WT HPV16) or the HPV16 genome with a frameshi
nuclear size was measured in transfected (GFP-positive) cells. A) Representative microgra
experiment; three independent experiments). Data are plotted as the average±S.E.M. C) Im
mutant HPV16 genome was conﬁrmed by the presence of the HPV16 E7 oncogene by immorder to identify transfected cells, we co-transfected the genomic
HPV16 constructs with pEGFP, a plasmid that expresses GFP (Fig. 2A).
In the original report using this mutant HPV16 genome, the failure
to express the E5 gene had no effect on the viral life cycle or on the
growth and differentiation of the cells expressing HPV16 E5 fs genome
(Genther et al., 2003). Thus, the differences in cell morphology are
likely due to the loss of E5 rather, since the mutant HPV16 appears
otherwise functional.
Quantiﬁcation of the nuclei size from 500 cells reveals that
expression of the entire HPV16 genome can increase the cell's nuclear
size. Cells expressing the HPV E5 fs, had a slight increase in nuclear
size as compared to cells transfected with the pEGFP alone, but was
less than the wild type HPV16 (Fig. 2B). Both the wild type HPV16 and
HPV16 E5 fs had comparable levels of E7 expression [within 10% for
each experiment as determined by densitometric analysis of non-
saturated immunoblots (n=3); data not shown], indicating the
differences were not due to variation in transfection efﬁciency of the
intact virus (Fig. 2C). One explanationmay be that other HPV16 genes,
such as E7, contribute to an increase in nuclear size (Duensing et al.,
2009).
Together, these data indicate that HPV16 E5 is necessary and
sufﬁcient to induce enlarged nuclei in HaCaT cells. This ﬁnding is
remarkable because changes in nuclear size and morphology are one
of the diagnostic criteria for the presence of precancerous lesions and
cancer (Crum and Lee, 2006; Wright et al., 2004).
The HPV16 E5-mediated increase in nuclear size is associated with
doubling of the cell chromosomal content
In order to identify the cause of the enlarged nuclei, we ﬁrst
examined the amount of DNA in each cell. HaCaT cells were uninfected
or infected with adenovirus encoding HPV16 HA-E5 in the absence ore in nuclear size. HaCaT cells were transfected with pEGFP alone or co-transfected with
ft mutation in the E5 gene (HPV16 E5 fs). After recovery (72 h), cells were ﬁxed, and the
phs of each transfection condition. B) Quantiﬁcation of N500 cells (at least 150 cells/
munoblot of cells treated in parallel to those used in (A). Expression of the wild type and
unoblot.
345L. Hu et al. / Virology 405 (2010) 342–351presence of tetracycline to regulate protein expression. At various times
after infection, cells were collected and incubated with propidium
iodide to stain the DNA. Cells were analyzed by ﬂuorescent associated
cell sorting (FACS). In cells expressing HPV16 HA-E5, there was a time-
dependent increase in the percentage of cells that had twice (or more)
the normal chromosomal content (4C) (Fig. 3A). Uninfected HaCaT cells
and cells that did not express HPV16 HA-E5 (HA-E5+tet) did not show
signiﬁcant increases in the percentage of 4C cells over the course of 72 h
(Fig. 3B).
We next wanted to know if the increase in DNA content was a
function of the level of HPV16 E5 expression. Taking advantage of the
tetracycline-regulatable promoter, we added varying amounts of
tetracycline to cells that had been infected with the same amount of
HPV16 HA-E5 adenovirus. As shown in Fig. 4A, this allowed us toFig. 3. Expression of HPV16 E5 causes an increase in DNA content per cell with time. A) DNA
infected with adenovirus encoding for HA-E5 in the absence (HA-E5) or presence of tetrac
iodide, and analyzed by FACS. A representative analysis is shown with the 2C (left) and 4C (r
B) Graphical distribution of the cellular DNA content. Data are plotted as the percentage of diplo
(n=4). * indicates a p-value of b0.05 (two-tailed, unpaired t-test) as compared to cells infectedetermine the effect of a range of HPV16 E5 concentrations of cellular
DNA content. As predicted, higher concentrations of HPV16 HA-E5
resulted in a decrease in the percentage of 2C cells and a concomitant
increase in the percentage of 4C cells (Fig. 4B and C). These data are
consistent with the observation that less efﬁcient methods of protein
expression (i.e. transfection) produce less robust increases in nuclear
size (Fig. 2 and Supplemental Fig. 2).
To determine whether the enhanced DNA content per cell reﬂects
an increased chromosomal content, HPV16 E5 expressing cells were
subjected to ﬂuorescence in situ hybridization (FISH) analysis, probing
with a marker for the X chromosome (Fig. 5A). In cells expressing
HPV16 HA-E5, there was greater than 15-fold increase in the
percentage of cells expressing four copies of the X chromosome as
compared to control cells (Fig. 5B). The increase in chromosomecontent distribution of HPV16 E5 expressing cells. tTA-HaCaT cells were uninfected or
ycline (HA-E5+tet). At the indicated times, cells were ﬁxed, stained with propidium
ight) cells in red, the S-phase cells in grey, and the cells greater than tetraploid in green.
id and polyploidy (tetraploid or greater) cells in each phase. Shown is the average±S.E.M.
d in the presence of tetracycline.
Fig. 4. HPV16 E5 mediated increase DNA content per cell is dose dependent. A) tTA-HaCaT cells were infected with or without adenovirus encoding for HA-E5 in the presence of the
indicated concentrations of tetracycline (0–25 ng/ml). Following infection (48 h), cell lysates (80 μg) were prepared, separated on a 16% Tris–tricine gel, and immunoblotted with an
anti-HA or an anti-α-tubulin antibody. B) tTA-HaCaT cells from (A) were ﬁxed, propidium iodide stained, and analyzed by FACS. A representative analysis is shownwith the 2C (left)
and 4C (right) cells in red, the S-phase cells in grey, and the cells greater than tetraploid in green. C) Summary of the DNA content distributions as in (B). Data are plotted as the
percentages of 2C, 4C, and ≥4C cells. Shown is the average±S.E.M. (n=4). * indicates pb0.05; ** indicates pb0.01 (two-tailed, unpaired t-test) when compared to no virus control.
346 L. Hu et al. / Virology 405 (2010) 342–351number was accompanied by an increased nuclear size (Fig. 5C). Thus,
the observed morphological and biochemical phenotypes correspond
to changes in chromosome content.
Molecular basis of enlarged nuclei
Given the strong association of these cellular changes with the
development of cancer, we wanted to know how these cellular
changes were arising with the long-term goal of speciﬁcally inhibiting
them. We identiﬁed three mechanisms by which cells could have
twice the number of chromosomes in one enlarged nuclei: 1) two cells
could fuse together and subsequently their nuclei fuse together, 2)
cells could replicate DNA, undergo mitosis but fail to segregate
chromosomes successfully or fail cytokinesis, or 3) cells could
undergo endoreplication (Storchova and Pellman, 2004). These
three possibilities were systematically tested.We have previously reported that expression of HPV16 E5 causes
cell–cell fusion (Hu et al., 2009). We wanted to know if the enlarged
polyploidy nuclei in HPV16 E5-expressing cells were the result of
nuclear fusion subsequent to cell–cell fusion. To answer this question,
we transfected separate populations of tTA-HaCaT cells with either
histone 2B tagged with yellow ﬂuorescent protein (YFP) or red
ﬂuorescent protein (RFP) that allows for differential labeling of nuclei.
These cells were mixed together in a 1:1 ratio and infected with the
HPV16 HA-E5 adenovirus. At 24-h intervals, cells were ﬁxed and
processed by indirect immunoﬂuorescence using an anti-HA anti-
body. We examined over 1000 cells from three different experiments
(300–400 cells/experiment) and observed the formation of hetero-
karyons (Hu and Ceresa, 2009). In all cases, cells with enlarged nuclei
express only one of the ﬂuorescent proteins (data not shown). Based
on these data, we conclude that cell–cell fusion does not precede the
formation of enlarged nuclei.
Fig. 5.HPV16 E5 increases the percentage of polyploidy cells. A) Images of uninfected tTA-HaCaT cells (No Virus) or cells infected with HPV16 HA-E5 adenovirus in the absence (HA-
E5) or presence of tetracycline (HA-E5+tet). After recovery (72 h), cells were ﬁxed and processed for ﬂuorescence in situ hybridization (FISH) staining for the X chromosome
(described in Materials and methods). The X chromosome stained in green and the nuclei stained blue. Size bar=10 μm. B) Quantiﬁcation of the percentage of cells containing 2, 4,
or N4 copies of the X chromosome. Data are plotted as the average percentage±S.E.M. from three independent experiments (N400 cells per condition). C) Tetraploid cells have a
larger nucleus than diploid cells. The average nuclear diameter of HPV16 E5 expressing cell was measured and plotted as a function of the chromosome number. Shown are the
average±S.E.M. for N100 cell for each condition. * indicates pb0.05 (two-tailed, unpaired t-test).
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through cytokinesis, we expressed HPV16 E5 in HaCaT cells and
monitored their rate of cell division using live cell video microscopy.
HPV16 E5-expressing and control cells were monitored for the time
between complete nuclear breakdown and separation in to two
individual cells. All HPV16 E5-expressing cells were able to divide,
albeit with slight differences in the rate of cytokinesis. Surprisingly,
there was a trend in which HPV16 E5-expressing cells went through
mitosis more rapidly than control cells (Fig. 6A).
To be certain we were not selecting for a sub-population of HPV16
E5 positive cell that could undergo cell division, we monitored HPV16
E5 positive cells for chromosomal condensation. Cells were ﬁrst
transfectedwith red ﬂuorescent protein-tagged histone 2B (RFP-H2B)
and subsequently infected with HPV16 E5. RFP-H2B localizes
exclusively to the nucleus and provides a clear indication of nuclear
size and structure. After recovery for 24 h, cells were imaged using
live cell video microscopy to monitor the development of enlarged
nuclei. This assay allowed us to determine if progression through
mitosis and cytokinesis, either normal or aberrant, was a prelude to
the formation of enlarged nuclei.
We did not identify any cells that entered mitosis immediately
prior to developing enlarged nuclei. This indicates that the develop-
ment of enlarged nuclei can occur without progression into mitosis. In
addition, live cell imaging provided direct evidence that the enlarged
nuclei did not result from two nuclei merging after cell–cell fusion. In
contrast, video microscopy provided clear evidence that the enlarged
nuclei developed through a steady increase in nuclear size.
Shown are representative micrographs documenting the growth
of the nuclei in cells that are HPV16 E5 negative (Fig. 6B) and positive
(Fig. 6C and D) cells over the course of 24 h (Representative movies
are included as Supplemental Movies 1–3). These cells, and the more
than 100 other cells that we monitored, exhibited a steady increase in
nuclear diameter with no indication of mitotic chromosome conden-
sation prior to the enlargement of the nuclei. Shown in Fig. 6E is the
time-dependent change in nuclear size of ﬁve HPV16 E5 positive cells
(solid lines) and ﬁve HPV16 E5 negative (dashed lines) cells. In all
cells, the nucleus continually increases, but the rate of increase ismuch faster with higher expression of HPV16 E5. Thus, although
HPV16 E5 expressing cells divide (Fig. 6A), the development of
enlarged nuclei is independent of cell division or of cell–cell fusion
(Fig. 6B and C).
The third possible explanation for how the enlarged nuclei arise is
through endoreplication. Endoreplication is broadly deﬁned as
multiple rounds of DNA synthesis without cell division. The live cell
imaging data (Fig. 6), the increase in DNA content (Figs. 3 and 4), and
the doubling of chromosomal number (Fig. 5) are consistent with the
notion that the increased nuclear size arises from multiple rounds of
cell division.
We postulated that if the increased nuclear size were due to
endoreplication, then the increase in nuclear size would be dependent
on DNA synthesis. Therefore, inhibition of DNA synthesis would
prevent the increase in nuclear size. To test this hypothesis, we
incubated cells with hydroxyurea, a pharmacological agent that
reduces the production of deoxyribonucleotides via inhibition of the
enzyme ribonucleotide reductase (Sinclair, 1965). In the absence of
deoxyribonucleotides, DNA synthesis is terminated. HPV16 E5
expressing cells were incubated with or without hydroxyurea for
24 h intervals (schematic in Fig. 7A). Cells were ﬁxed, immunostained
with an antibody against the HA epitope, the nuclei were stained with
DAPI, and the nuclear size was monitored as described previously.
Shown in Fig. 7B are representative micrographs. In the absence of
hydroxyurea, the nuclear size of HPV16 E5-expressing cells grew in a
time-dependent manner, as shown previously. However, in the
absence of DNA synthesis, the growth in nuclear size was arrested
(Fig. 7C). These data indicate that DNA synthesis is required for the
increase in nuclear size.
Discussion
In this study, we show that expression of HPV16 E5 is sufﬁcient to
increase nuclear size in both HaCaT and NIH3T3 cells. This phenotype
also arises when the E5 gene is expressed in the context of the entire
HPV16 genome. The increased nuclear size is dependent both on the
level and duration of HPV16 E5 expression and is accompanied by a
Fig. 6. Enlarged nuclei are not the result of failed cytokinesis. A. tTA-HaCaT cells were infected with nothing (no virus) or HPV16 E5 encoding adenovirus in the absence (HPV16 E5)
or presence of tetracycline (HA-E5+tet). Cells were monitored using a Zeiss Axovert 200 M microscope equipped with a Hamamatsu ORCA camera. Mitosis times were calculated
from more than 40 cells from three different experiments as described in “Materials and methods”. Data are displayed as a Box andWhisker graph with the SEM. B. tTA-HaCaT cells
were transfected with RFP-H2B for 24 h and then infected with HPV 16 HA-E5 adenoviruses infection for 2 h, change into growth media after infection. Twenty-four hours after
infection, RFP-H2B or YFP-H2B transfected cells were monitored 24 h under Nikon microscope with Photometrics Cool Snap HQ camera. Time-lapse phase-contrast images were
collected and processed with NIS-Elements AR 3.0, SP5 Software. C. The increase in nuclear size is a continual process. The nuclear size was measured at 0 h, 8 h, 16 h and 24 h. A
shows the represented nuclei. B shows the change of multiple nuclei size at 8 h, 16 h and 24 h in comparison to 0 h.
348 L. Hu et al. / Virology 405 (2010) 342–351doubling of the number of chromosomes. We have eliminated cell–
cell fusion and failed cytokinesis as potential mechanisms by which
these tetraploid cells are arising. Based on our observation that the
enlarged nuclei arise through a continual growth and is dependent
upon DNA synthesis for that growth, we have concluded these
morphological changes occur due to endoreplication.
This ﬁnding provides important mechanistic insight to the ﬁndings
of others. Krawczyk et al. (2008) have also reported changes in the
nuclear morphology as the result of HPV16 E5 expression. In that study,the authors examined the synergistic effect of HPV16 E5 and E6 in the
development of koilocytosis. Although there are differences in the
nuclearmorphology in the two reports, it is likely that these differences
reﬂect the level of protein expression and the cell lines examined.
Another study, by Genther et al. (2003), demonstrated that in the
context of the entire HPV16 E5 genome, the loss of E5 decreased the
extent of DNA synthesis. Using organotypic keratinocyte raft cultures
expressing the wild type HPV16 genome or the HPV16 E5 fs mutant, the
authors monitored DNA synthesis in cells expressing the virus. In the
Fig. 7. Formation of enlarged nuclei requires DNA synthesis. A) Schematic of treatment of cells. tTA-HaCaT cells were grown on coverslips and infected with HPV16 HA-E5 adenovirus
at time=0 h. At 24 h intervals, the media was changed to growth media or growth media supplemented with 0.5 mM hydroxyurea (+HU) and indicated. At 24 h intervals, cells
were ﬁxed, subjected to indirect immunoﬂuorescence using the 12CA5 antibody (Roche) and DAPI staining. B) Representative micrographs showing 12CA5 positive cells (green) and
DAPI-stained nuclei (blue). The nuclear sizewasmeasured as described inMaterials andmethods. C) Nuclear size from each of the 5 conditions. Data are presented as the average±S.E.M.
(n=3) with at least 50 nuclei measured per condition in each experiment. Statistical signiﬁcance was determined using a Student's t-test.
349L. Hu et al. / Virology 405 (2010) 342–351absence of E5, there was a 50% decrease in BrdU incorporation. The
change DNA synthesis is consistent with the idea that E5 is responsible
for the changes innuclear size andchromosomenumber thatweobserve.
There have been a number of roles ascribed to HPV16 E5 in
mediating oncogenesis. However, most of the previously proposed
functions are inconsistent with the kinetics of E5 mRNA expression
following HPV16 infection (Stoler et al., 1992) and a role for E5 in
cancer initiation (zur Hausen, 1996, 2000). In contrast to the
previously described roles for HPV16 E5, HPV16 E5-mediated
endoreplication is consistent with its role in initiating oncogenesis.
The ability of HPV16 E5 to promote endoreplication, like cell–cell
fusion (Hu and Ceresa, 2009; Hu et al., 2009), indicates that HPV16 E5makes fundamental modiﬁcations to the host cell's chromosome by
inducing polyploidy. It has been demonstrated by others that
polyploid cells are a frequent occurrence in precancerous cervical
lesion (Olaharski et al., 2006). Further, in tissue culture models, it has
been shown that mitosis of polyploid cells frequently produces
aneuploid cells (King, 2008). This is thought to be because cells are not
equipped to properly segregate twice the number of chromosomes
and the subsequent gain or loss of a chromosome(s) and the
generation of an aneuploid cell. Aneuploidy is a characteristic of
nearly all cancers (Sen, 2000). The gain or loss of chromosomes can
result in cellular changes such as an increased rate of cell growth or
migration, or resistance to apoptosis.
350 L. Hu et al. / Virology 405 (2010) 342–351Inmost cells, the failure of a cell to have the normal complement of
chromosomes results in the induction of apoptosis or quiescence. The
presence of the HPV16 E6 and E7 genes increases the possibility that
polyploid cells will divide, since they inhibit genes that regulate cell
cycle checkpoints. Polyploid cells that develop as the result of E5-
mediated endoreplication are a potential initiating event for aneu-
ploidy, and subsequently oncogenesis to occur. However, we cannot
rule out the possibility that other cellular insults also enhance the
transition to oncogenesis.
By their very nature, all viral proteins are introduced into the cell by
exogenous expression. It is likely that the exogenous expression system
used in our studies produces levels of HPV16 E5 that are greater than
those that occur as the result of infection by HPV16. Although in the
absence of antibodies against the native E5, that is not known with
certainty. However, this methodology allows us to amplify the
frequency and magnitude of a phenotype that may be less obvious at
lower levels of protein expression. In fact, if infection with HPV16 were
to produce such frequent and profound changes in cell morphology as
we observe with our expression system, it is likely that the incidence of
cancerwould bedramatically increased. Fortunately, this is not the case.
Only a small percentage of HPV-positive individuals develop cancer.
Deciphering the functional role of HPV16 E5 in viral replication
and oncogenesis has been difﬁcult. Numerous roles have been
ascribed to this protein, many of which appear unrelated. Our own
work has revealed two novel phenotypes induced by HPV16 E5
expression: binucleated cells (Hu et al., 2009) and enlarged, polyploid
nuclei. Live cell video microscopy to date has not provided evidence
for a direct link between the two phenotypes. However, this does not
eliminate the possibility that they are related.
The morphological and chromosomal changes we observe are
noteworthy because they frequently accompany the progression of
normal cells into cancerous cells. Increased nuclear size, increased DNA
content, and tetraploidy are characteristic of low grade squamous
intraepithelial lesions (LSIL) (Mittal et al., 1990; Prasad et al., 1993).
Many of these changes are criteria used in the clinical detection of
cervical cancer precursors in screening Pap tests (Crum and Lee, 2006;
Wright et al., 2004). Additional characteristics of precancerous lesions
have also been reported: the presence of binucleated cells, increased
DNAcontentper cell, andpolyploidy (Olaharski et al., 2006). Theseother
morphological changes are not used in the diagnosis of precancerous
lesions despite the fact they are less subjective because of the amount of
material, time, and expense used to detect them. Our studies
complement previous reports describing the oncogenic capacity of
HPV E5 (Leechanachai et al., 1992; Straight et al., 1993) and offer
mechanistic insights into how E5 expression brings about morpholog-
ical changes in the cervical epithelium. Further, by identifying
endoreplication as the mechanism by which the aberrant nuclei form
and increase DNA synthesis arises, there is now a biological process that
can be targeted to inhibit oncogenesis.
Materials and methods
Tissue culture cells
Parental HaCaT, tTA-HaCaT (Hu et al., 2009), and NIH 3T3 cells
were maintained in Dulbecco's minimal essential media (DMEM) of
10% fetal bovine serum (FBS), 100 units/ml penicillin, 100 units/ml
streptomycin, and 2 mM glutamine. Stably transfected tTA-HaCaT
cells were supplemented with 800 μg/ml G418. All cell lines were
maintained at 37 °C in 5% CO2.
Adenovirus generation/expression
Codon-optimized HPV16 E5 was generated as previously de-
scribed (Disbrow et al., 2003). Hemagglutinin (HA) epitope
(MEYDVPDYAH) was engineered on to either the amino (HA-E5) orcarboxyl (E5-HA) terminus of the protein by PCR, making the
appropriate modiﬁcation of stop codons. Adenoviruses were gener-
ated using Clontech Adeno-X™ Tet-off expression system. All
adenoviruses were sequenced at the DNA sequencing facility at the
Oklahoma Medical Research Foundation.
Cells were infected with adenoviruses that had been CsCl puriﬁed.
Cells were infected with ∼20 plaque forming units of adenovirus per
cell in serum-free DMEM for 2 h at 37 °C. Following incubation, the
adenovirus containing media was removed and replaced with growth
media. Tetracycline (1 μg/ml) was added during adenoviral infection
and recovery.
Plasmids and transfection
HA-tagged, codon-optimized HPV16 E5 was generated as de-
scribed above and subcloned into either the pcDNA3 (Invitrogen) or
pCDF1-MCS2-EF2-copGFP (System Biosciences).
The wild type HPV16 genome and E5 frameshift mutation were
cloned into a pUC-18 plasmid for the replication and antibiotic
selection for puriﬁcation (Genther et al., 2003). Prior to transfection,
CsCl puriﬁed cDNA (10 μg) was digested with BamH1 to isolate the
HPV16 genome from the backbone plasmid and the result ∼8000 bp
DNA fragment was isolated by gel puriﬁcation. The HPV16 genome
(2 μg) along with GFP-neomycin (pEGFP-C1; Clontech) was intro-
duced into 2×106 HaCaT cells by nucleofection (Amaxa).
NIH 3T3 cells were transfected with the indicated plasmids using
Lipofectamine 2000, according the manufacturer's directions.
Cell lysates and immunoblotting
Cell lysates were prepared as previously described (Dinneen and
Ceresa, 2004). Proteins were resolved on 16% Tris–tricine gels and
transferred to nitrocellulose. Antibodies were obtained from the
indicated sources: anti-HA (University of Virginia Lymphocyte
Culture Core), α-tubulin (Sigma), HPV16 E7 (Zymed). Proteins were
visualized with enhanced chemiluminescence and documented using
a UV Products Imaging system.
Indirect immunoﬂuorescence
Indirect immunoﬂuorescence was performed as previously de-
scribed (Dinneen and Ceresa, 2004). The 12CA5 antibody (University
of Virginia Lymphocyte Culture Core) was used at a dilution of 1:1000
as the primary antibody and Alexa 488- or Alexa 568-conjugated goat
anti-mouse (Molecular Probes) as the secondary antibody at a
dilution of 1:250. Cells were also stained with 1 ng/ml DAPI
(Sigma). Images were captured using Olympus AX70 epiﬂuorescent
microscope with Q-Capture software.
Fluorescence in situ hybridization (FISH)
Cells were ﬁxed and processed for FISH using the AneuVysion
probe (Vysis) according to manufacturer's protocol.
FACS analysis
Cells were ﬁxed in 70% ethanol, and incubated with 200 μg/ml
propidium iodide (Sigma) for 1 h. Cells were analyzed using a FACS
Calibur (Benton Dickson). The data from 10,000 cells/experiment
were analyzed using Modﬁt LT 2.0 software (Verity).
Assessment of nuclear size
Images of DAPI-stained nuclei were analyzed using Photoshop
software to convert pixel length into microns. Where indicated, cells
were incubatedwith 0.5 mMhydroxyurea (Sigma) dissolved in growth
media.
Live cell imaging
For monitoring progression through mitosis and cytokinesis, cells
were analyzed by video microscopy for 24 h using a Zeiss Axovert
200M microscope equipped with a Hamamatsu ORCA camera.
351L. Hu et al. / Virology 405 (2010) 342–351Mitosis time was calculated and the length of time it took cells to
progress from prophase (chromosomal condensation) to separate
into two daughter cells. For each condition, at least 10 ﬁelds con-
taining 3–8 cells/condition were observed. From those, the rate of
mitosis was calculated from 40 to 53 cells for each condition.
In experiments in which the nuclear size was monitored, HaCaT
cells were transfected with red ﬂuorescent protein-tagged histone 2B
(RFP-H2B) allowed to recover for 24 h before infection with
adenovirus. After recovery from adenoviral infection, cells were
monitored 24 hwith a Nikonmicroscope equippedwith Photometrics
Cool Snap HQ camera. Time-lapse phase-contrast images were
collected and processed with NIS-Elements AR 3.0, SP5 Software.
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